Orphan drugs face “uphill battle” in 2020
EMA-assigned Orphan Drug Designations declined 49% between 2014 and 2019.
Read More
Author: Anna Smith
COVID-19: Takeda, Arcturus, Veeva all chip in
The UK has reported its biggest overnight jump in cases, bringing the total to 87 infected patients.
Read More
Four pharma companies found guilty of anti-competitive behaviour
Ultimately, the CMA is fining King and Accord-UK £75,573 and £1,882,238 respectively, with Accord-UK and Auden agreeing to make a £1 million payment to the NHS.
Read More
App to determine risk of preterm birth developed
When babies are born early, before 37 weeks of pregnancy, they are more likely to die, or have physical, developmental and emotional problems.
Read More
First patient dosed in potential lymphoedema treatment trial
The drug being evaluated is an oral, small molecule drug candidate known as deupirfenidone.
Read More- Transgene completes randomisation in phase 2 trial of tg4050
- Bayer wins MHRA approval for Kerendia in heart failure
- Oxford BioTherapeutics signs collaboration with Bristol Myers Squibb
- Kainova expands DT 7012 trial into Europe
- Amgen reports positive phase 3 results for subcutaneous TEPEZZA in thyroid eye disease
